All In MedTech

Device Trial Radar · NCT06275685

Forecasting Seizures Using Intelligent Wearable Technology for Health Tracking

Forecasting Seizures Using IntelliGent Wearable Technology for Health Tracking

Last checked: Nov 19, 2026Latest source record: Sep 19, 2024 (this record)Source: ClinicalTrials.govMethods & limitations

Status unknownPivotal-lookingRandomized with 3,000 participants. This is a heuristic, not a regulatory label.

Status

Status unknown

Enrollment

3,000

Planned (sponsor's estimate)

Start

Apr 11, 2024

Primary completion

Jun 2026

Study completion Jun 2026

Sponsor

Lead sponsor
Empatica, Inc.Not on our public-company list
Sponsor type
Industry
First posted
Feb 23, 2024

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Randomized
Model
Parallel
Masking
None
Primary purpose
Other
FDA-regulated device
Yes
Who can join
All sexes, from 6 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The goal of this interventional study is to develop a personalized seizure risk forecast tool in people with epilepsy. The main questions it aims to answer are: * can we develop a future seizure probabilities tool that is more accurate than chance based on the pattern and frequency of previous generalized tonic-clonic seizure (GTCS) events, as well as changes in physiological and behavioral variables. * does this tool improve the lives of people with epilepsy? Researchers will compare a group that does not have access to the forecast tool to a group that does and see if it is accurate and if people with it report that it improved their quality of life.

Conditions

  • Epilepsy; Seizure

Interventions

  • SeizureWise algorithmDevice

    An investigational algorithm which enables forecasting of future seizure probabilities based on the pattern and frequency of previous generalized tonic-clonic seizure (GTCS) events, as well as changes in physiological and behavioral variables

  • Multi-day VisualizationsDevice

    Multi-day visualizations of sensor derived data

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Sensitivity of SeizureWiseTime frame: 2 years

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Empatica

    Boston, Massachusetts · Recruiting

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.